Palliative radiotherapy in symptomatic locally advanced gastric cancer: A phase II trial

To evaluate the response and quality of life of palliative gastric radiotherapy in patients with symptomatic locally advanced gastric cancer. Patients with bleeding, pain or obstruction and were treated with palliative gastric radiotherapy to a dose of 36 Gy in 12 daily fractions. The primary outcom...

Descripción completa

Detalles Bibliográficos
Autores principales: Tey, Jeremy, Zheng, Huili, Soon, Yu Y., Leong, Cheng N., Koh, Wee Y., Lim, Keith, So, Jimmy B. Y., Shabbir, Asim, Tham, Ivan W. K., Lu, Jiade
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488108/
https://www.ncbi.nlm.nih.gov/pubmed/30790469
http://dx.doi.org/10.1002/cam4.2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488108/
https://www.ncbi.nlm.nih.gov/pubmed/30790469
http://dx.doi.org/10.1002/cam4.2021

Ejemplares similares